NCT06411366View on ClinicalTrials.gov

Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans

PHASE1CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

FrailtyAging

Interventions

GENETIC

Follistatin plasmid

Follistatin-344 plasmid

Trial Locations (1)

Unknown

Global Alliance for Regenerative Medicine, Roatán

All Listed Sponsors

lead

Minicircle

INDUSTRY